company background image
CJH logo

CanSino Biologics BST:CJH Stock Report

Last Price

€2.00

Market Cap

€960.0m

7D

0%

1Y

-61.2%

Updated

27 Mar, 2024

Data

Company Financials +

CanSino Biologics Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CanSino Biologics
Historical stock prices
Current Share PriceHK$2.00
52 Week HighHK$5.17
52 Week LowHK$1.93
Beta0.62
1 Month Change-2.05%
3 Month Change-20.20%
1 Year Change-61.23%
3 Year Change-93.37%
5 Year Changen/a
Change since IPO-57.84%

Recent News & Updates

Recent updates

Shareholder Returns

CJHDE BiotechsDE Market
7D0%1.2%2.5%
1Y-61.2%34.7%7.0%

Return vs Industry: CJH underperformed the German Biotechs industry which returned 37% over the past year.

Return vs Market: CJH underperformed the German Market which returned 7.3% over the past year.

Price Volatility

Is CJH's price volatile compared to industry and market?
CJH volatility
CJH Average Weekly Movementn/a
Biotechs Industry Average Movement5.7%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: CJH's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine CJH's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20091,946Xuefeng Yuhttps://www.cansinotech.com

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination.

CanSino Biologics Inc. Fundamentals Summary

How do CanSino Biologics's earnings and revenue compare to its market cap?
CJH fundamental statistics
Market cap€960.05m
Earnings (TTM)-€184.97m
Revenue (TTM)€45.64m

10.1x

P/S Ratio

-2.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CJH income statement (TTM)
RevenueCN¥357.08m
Cost of RevenueCN¥0
Gross ProfitCN¥357.08m
Other ExpensesCN¥1.80b
Earnings-CN¥1.45b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Mar 28, 2024

Earnings per share (EPS)-5.87
Gross Margin100.00%
Net Profit Margin-405.31%
Debt/Equity Ratio43.8%

How did CJH perform over the long term?

See historical performance and comparison

Dividends

5.5%

Current Dividend Yield

186%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.